The University of Texas Health Science Center, Houston
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center, Houston sits in the top decile of US sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center, Houston: 732 sponsored US clinical trials, 144 recruiting.
The University of Texas Health Science Center, Houston sponsors 732 registered US clinical trials on ClinicalTrials.gov, 144 of them currently recruiting, and 436 completed. 98 of these trials are in Phase 3-4 (later-stage) and 139 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 8 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center, Houston ranks in the top decile of sponsors by registered trial count (#45 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
436 of 521 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
732 total, page 12 of 15
Pediatric Bipolar Registry
NCT02360267
Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury
NCT01851083
Brighter Bites - Access, Continuity and Education With Fruits and Vegetables
NCT02726529
Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea
NCT02318992
Cosmetic Outcome Study of Lid Laceration Repair With Suture Versus Tissue Adhesive
NCT01918059
Cesarean Skin Incision Trial
NCT01897376
Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
NCT02412761
Buspirone, Stress, and Attentional Bias to Marijuana Cues
NCT02132832
Patients With Intermittent Claudication Injected With ALDH Bright Cells
NCT01774097
Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes
NCT01818557
SIBO, Immune Activation, and FGIDs in Children
NCT02872961
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
NCT01888354
Initiation of Oral Feeding at 30 Versus 33 Weeks Postmenstrual Age
NCT01787019
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
NCT01797575
Diabetes Go Mobile! Pilot Study
NCT02858648
Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period
NCT02681419
Propaten Randomized Investigation on Cost-benefit and Efficacy
NCT01601873
Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis
NCT02006342
Haloperidol vs Conventional Therapy for Gastroparesis
NCT02057549
Text Messaging for Weight Loss
NCT01736111
It's Your Game: An Innovative Approach to Preventing Teen Dating Violence
NCT03482687
Motivational Incentives to Reduce Secondhand Smoke in NICU Infants' Homes
NCT01726062
PPARγ Agonist Treatment for Cocaine Dependence
NCT02774343
Pragmatic, Randomized Optimal Platelet and Plasma Ratios
NCT01545232
Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery
NCT01608308
Intravenous Acetaminophen in Craniotomy
NCT01598701
Topical Rapamycin to Erase Angiofibromas in TSC
NCT01526356
Genetic Risks for Bicuspid Aortic Valve Disease
NCT01823432
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
NCT01575470
Improving Signout Accuracy and Information Delivery in the Emergency Department
NCT01859286
Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic Women
NCT04426019
Longitudinal Sleeve Gastrectomy Study Comparing Posterior Crural Repair Versus No Repair
NCT01554553
Evaluation of Barriers to Postpartum Care in HIV Infected Women
NCT01853917
Hypertrophic Regression With N-Acetylcysteine in HCM
NCT01537926
Effect of Laser Use on Guided Tissue Regeneration in Treatment of Molar Teeth With Class 2 Furcation Affected by Periodontitis
NCT01522131
The Effect of the Amino Acid L-Theanine on Alertness and Vigilance
NCT01851122
A Randomized Recruitment Intervention Trial
NCT01911208
Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?
NCT01891279
Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic
NCT01279265
Symptom Management Program for Hemodialysis Patients
NCT01620580
Online Programs to Promote Colon Cancer Screening
NCT01411826
Hemophilia Inhibitor Previously Untreated Patient Study
NCT01652027
Cognitive Remediation for Cocaine Dependence
NCT01393457
Comparison of Storz C-MAC and D-MAC Orotracheal Intubation Systems in Morbidly Obese Patients
NCT01556061
Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
NCT01541397
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
NCT01214759
Early Whole Blood in Patients Requiring Transfusion After Major Trauma
NCT01227005
Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles
NCT02046317
Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy
NCT01286402
An Enhanced Medical Home for High-Risk Chronically Ill Children
NCT02128776
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 55 |
| Phase 2 | 84 |
| Phase 3 | 13 |
| Phase 4 | 85 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center, Houston pipeline
144 recruiting of 732 indexed (20% open); 436 completed (60%).
Phase mix: 98 late (III/IV) vs 139 early (I/II) (balanced across stages).
Top condition: Stroke (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center, Houston: open-pipeline peers nationwide
Peers matched on 732 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center, Houston sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 732 trials (± recruiting share)
- University of Miami · 721 trials · 20% recruiting
- Sanofi · 713 trials · 10% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- University of Chicago · 20% recruiting · 796 trials
Related
What to do with this The University of Texas Health Science Center, Houston page
732 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center, Houston or any single study.
- 144 of The University of Texas Health Science Center, Houston's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition The University of Texas Health Science Center, Houston studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center, Houston pipeline card: 732 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.